These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6451468)

  • 21. Comparative immunotoxicity assessment of N4-Trimethoxybenzoyl-5'-deoxy-5- fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice.
    Inoue T; Anderson TD; Hayes TJ; Horii I
    J Toxicol Sci; 1996 Feb; 21(1):29-39. PubMed ID: 8852286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective suppression of humoral and cellular immunity with cytosine arabinoside.
    Griswold DE; Heppner GH; Calabresi P
    Cancer Res; 1972 Feb; 32(2):298-301. PubMed ID: 4550745
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
    Fujita F; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
    Zimecki M; Wieczorek Z
    Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O; Mori H; Kitaichi K; Koda A; Kato T
    Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
    Mori H; Sakamoto O; Kitaichi K; Koda A; Kita J
    Jpn J Pharmacol; 1992 Mar; 58(3):269-82. PubMed ID: 1513076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 5-fluorouracil on direct and developed spleen hemolysin plaque-forming cells of mice.
    Griswold DE; Uyeki EM
    Arch Ital Patol Clin Tumori; 1969; 12(1):109-14. PubMed ID: 4918910
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanism of the chromosome damaging effect of ftorafur].
    Volgareva GM; Sokova OI; Pogosiants EE
    Genetika; 1977; 13(3):461-7. PubMed ID: 142687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of immunological responses in mice by treatment with amphotericin B.
    Ferrante A; Rowan-Kelly B; Thong YH
    Clin Exp Immunol; 1979 Oct; 38(1):70-6. PubMed ID: 527256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodepressive activity of FCE 23762 on humoral and cell-mediated immune responses in normal mice: comparison with doxorubicin.
    Fornasiero MC; Ferrari M; Gnocchi P; Trizio D; Isetta AM
    Agents Actions; 1992 Nov; 37(3-4):311-8. PubMed ID: 1295379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Action of ftorafur and 5-fluorouracil on the chromosomes of normal and tumorous cells in vivo].
    Sokova OI; Volgareva GM
    Vopr Onkol; 1977; 23(2):94-7. PubMed ID: 324124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of 5-fluorouracil and ftorafur[1-(tetrahydrofuran-2-yl)-5-fluorouracil] on murine mammary tumors and small intestine.
    Pallavicini MG; Cohen AM; Dethlefsen LA; Gray JW
    Cell Tissue Kinet; 1979 Mar; 12(2):177-89. PubMed ID: 371813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunotoxicological evaluation of gamma-chlordane.
    Johnson KW; Holsapple MP; Munson AE
    Fundam Appl Toxicol; 1986 Feb; 6(2):317-26. PubMed ID: 3486141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combined therapies with protein-bound polysaccharide (PSK, Krestin) and fluorinated pyrimidine derivatives on experimental liver metastases and on the immunologic capacities of the hosts.
    Tsuru S; Shinomiya N; Katsura Y; Gotoh M; Noritake M; Nomoto K
    Oncology; 1991; 48(6):498-504. PubMed ID: 1749590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorinated pyrimidine nucleosides. 4. Synthesis and antitumor testing of a series of 2',5'-dideoxy- and 2',3',5'-trideoxynucleosides of 5-fluorouracil.
    Cook AF; Holman MJ; Kramer MJ
    J Med Chem; 1980 Aug; 23(8):852-7. PubMed ID: 6447210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo.
    Michaelides M; Hogarth PM; McKenzie IF
    Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of prostaglandin E 1 on cellular and humoral immune responses.
    Loose LD; DiLuzio NR
    J Reticuloendothel Soc; 1973 Jan; 13(1):70-7. PubMed ID: 4144676
    [No Abstract]   [Full Text] [Related]  

  • 40. Suppression of cellular immunity in vivo by rifampicin.
    Floersheim GL
    Experientia; 1973 Dec; 29(12):1545-6. PubMed ID: 4589325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.